| Product Code: ETC7647609 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Celiac Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Celiac Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Celiac Disease Market - Industry Life Cycle |
3.4 Israel Celiac Disease Market - Porter's Five Forces |
3.5 Israel Celiac Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Israel Celiac Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Celiac Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Israel Celiac Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Celiac Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of celiac disease in Israel |
4.2.2 Growing demand for gluten-free products in the market |
4.2.3 Technological advancements in diagnostic tools and treatment options for celiac disease |
4.3 Market Restraints |
4.3.1 Limited availability of specialized gluten-free products in certain regions of Israel |
4.3.2 Lack of reimbursement policies for celiac disease treatment |
4.3.3 Challenges in adherence to a strict gluten-free diet among patients |
5 Israel Celiac Disease Market Trends |
6 Israel Celiac Disease Market, By Types |
6.1 Israel Celiac Disease Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Israel Celiac Disease Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Israel Celiac Disease Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.1.4 Israel Celiac Disease Market Revenues & Volume, By Larazotide Acetate, 2021- 2031F |
6.1.5 Israel Celiac Disease Market Revenues & Volume, By Gluten Free Diet, 2021- 2031F |
6.1.6 Israel Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Celiac Disease Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Celiac Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel Celiac Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Israel Celiac Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Celiac Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Celiac Disease Market Revenues & Volume, By homecare, 2021- 2031F |
6.3.4 Israel Celiac Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Celiac Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Celiac Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Israel Celiac Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Israel Celiac Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Celiac Disease Market Import-Export Trade Statistics |
7.1 Israel Celiac Disease Market Export to Major Countries |
7.2 Israel Celiac Disease Market Imports from Major Countries |
8 Israel Celiac Disease Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for celiac disease patients in Israel |
8.2 Percentage of healthcare professionals trained in celiac disease diagnosis and management |
8.3 Number of clinical trials or research studies focused on celiac disease in Israel |
8.4 Patient adherence rate to a gluten-free diet in Israel |
8.5 Rate of hospital readmissions for celiac disease-related complications in Israel |
9 Israel Celiac Disease Market - Opportunity Assessment |
9.1 Israel Celiac Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Israel Celiac Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Celiac Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Israel Celiac Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Celiac Disease Market - Competitive Landscape |
10.1 Israel Celiac Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel Celiac Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here